Thymol-Thymus vulgaris / BAD Cancer Research Results
TV, Thymol-Thymus vulgaris: Click to Expand ⟱
BAD, BCL2 associated agonist of cell death: Click to Expand ⟱
| Source: |
| Type: |
BCL2 associated agonist of cell death (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family.
Expression of the BAD is associated with the development and progression of cancer.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, AntiCan↑, PI3K↓, Akt↓, mTOR↓, NOTCH↓, PIK3CA↓, EGFR↓, Hif1a↓, VEGF↓, ChemoSen↑, RadioS↑, eff↝, *cardioP↑, *neuroP↑, *hepatoP↑, Apoptosis↑, MMP↓, Casp3↑, ROS↑, DNAdam↑, eff↑, BAX↑, BAD↑, FasL↑, Cyt‑c↑, Casp9↑, Casp8↑, TumCCA↑, P21↑, Smo↓, Gli1↓, JNK↑, ERK↓, MAPK↓, TRPM7↓, Wnt/(β-catenin)↓, BioAv↝, BioAv↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
PIK3CA↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAD↑, 1, BAX↑, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 1, FasL↑, 1, JNK↑, 1, MAPK↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, Gli1↓, 1, mTOR↓, 1, NOTCH↓, 1, PI3K↓, 1, Smo↓, 1, TRPM7↓, 1, Wnt/(β-catenin)↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, BioAv↝, 1, ChemoSen↑, 1, eff↑, 1, eff↝, 1, RadioS↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1,
Total Targets: 36
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Functional Outcomes ⓘ
cardioP↑, 1, hepatoP↑, 1, neuroP↑, 1,
Total Targets: 4
Scientific Paper Hit Count for: BAD, BCL2 associated agonist of cell death
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:161 Target#:426 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page